CHEUNG ANTHONY TZEYEW 4
4 · enGene Holdings Inc. · Filed Oct 22, 2024
Insider Transaction Report
Form 4
CHEUNG ANTHONY TZEYEW
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-21+100,000→ 100,000 totalExercise: $9.83Exp: 2034-10-21→ Common Shares (100,000 underlying)
Footnotes (1)
- [F1]This option vests at 25% on October 21, 2025, which is the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years, subject to Dr. Cheung's continued service.